Free Practice Questions for Stručni ispit za magistre farmacije

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card

40+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More Serbia Healthcare Professional Examinations (Stručni ispiti zdravstvenih radnika)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Serbia Nursing Professional Exam — Stručni ispit za medicinske sestre i tehničare (Ministarstvo zdravlja)

Practice Questions40 questions

Serbia Physician Professional Exam — Stručni ispit za doktore medicine (Ministarstvo zdravlja)

Practice Questions40 questions

Exam Review

Key Facts: Stručni ispit za magistre farmacije Exam

26 weeks

Supervised internship under the relevant programme

Pravilnik 33/2019

30 days

Minimum interval before repeating the examination

Pravilnik 33/2019, Article 11

Independent practice items, not an official question count

Independent English-language MCQ study adaptation, not an official translation, format simulation, or substitute for oral answers, written responses, or practical pharmacy training. Official materials are in Serbian, but permitted assessment languages are not specified in the reviewed sources; confirm the language and assigned oral or written mode with the Ministry.

Sample Stručni ispit za magistre farmacije Practice Questions

Try these sample questions to review concepts for the Stručni ispit za magistre farmacije exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 40+ question experience with AI tutoring.

1In Serbia's healthcare system, routine community-pharmacy dispensing and pharmaceutical care for the population belong principally to which level of care?

A.Primary healthcare

B.Tertiary specialist referral care

C.Secondary inpatient care

D.Specialised inpatient rehabilitation

Explanation: Community pharmaceutical care is a primary-healthcare activity under Serbia's healthcare framework. Hospital-pharmacy services have a different setting; the classification does not remove the pharmacist's professional and regulatory responsibilities.

2Which Serbian authority issues medicine marketing authorisations and evaluates medicine quality, safety, and efficacy?

A.Agencija za lekove i medicinska sredstva Srbije (ALIMS)

B.Republički fond za zdravstveno osiguranje (RFZO)

C.Farmaceutska komora Srbije

D.Institut za javno zdravlje Srbije Dr Milan Jovanović Batut

Explanation: ALIMS is Serbia's Medicines and Medical Devices Agency and performs these regulatory functions. Marketing authorisation is distinct from reimbursement decisions, professional-chamber licensing, and public-health surveillance.

3Which description best distinguishes a magistralni lek from a galenski lek in Serbian pharmaceutical terminology?

A.Magistral medicines are necessarily non-prescription industrial products

B.Galenic medicines are defined solely by being herbal products

C.The terms distinguish imported from domestically manufactured industrial medicines

D.A magistral medicine is prepared for an individual patient on prescription; a galenic medicine is prepared under the regulated galenic-laboratory framework using recognised formulations

Explanation: Magistral preparation is linked to a prescription for a particular patient. Galenic preparation has its own regulated laboratory and formulation requirements; neither term simply denotes a product's country of origin or whether it contains plant material.

4Under Serbia's prescription rulebook, an ordinary non-renewable prescription is issued for a registered medicine. It is not an antibiotic, a controlled psychoactive medicine, or an emergency prescription. What is its usual validity from the prescribing date?

A.3 days

B.30 days

C.7 days

D.15 days

Explanation: The usual validity for a non-renewable prescription is 15 days. The rulebook specifies different periods for particular categories, so this answer must not be applied indiscriminately to antibiotic, controlled, emergency, unregistered-medicine, or renewable prescriptions.

5Which activity best expresses the patient-care purpose of Dobra apotekarska praksa (Good Pharmacy Practice)?

A.Selecting the medicine with the largest sales margin before reviewing the prescription

B.Treating prescription review as unnecessary when an electronic prescription is available

C.Reviewing therapy for safety and appropriateness and helping the patient use medicines effectively

D.Dispensing without counselling whenever a package leaflet is supplied

Explanation: Good Pharmacy Practice places safe, effective medicine use and patient welfare at the centre of pharmaceutical services. Prescription review, counselling, documentation, and management of identified problems contribute to that purpose.

6A pharmacist suspects that a newly started medicine caused a serious adverse reaction. Causation has not been proved. What is the appropriate pharmacovigilance response in Serbia?

A.Report only if the reaction is absent from the product information

B.Wait for a rechallenge to prove causation before reporting

C.Support urgent clinical care as needed and submit a suspected-reaction report through the ALIMS reporting pathway

D.Send the report only to RFZO because it reimbursed the medicine

Explanation: Suspected adverse reactions should be reported through the ALIMS pharmacovigilance pathway without waiting for proof of causation. Reporting complements, rather than replaces, appropriate clinical care and follow-up; known reactions can also warrant reporting.

7Which event meets a standard regulatory criterion for a serious adverse drug reaction, regardless of whether the symptoms are described as mild or severe?

A.Transient nausea that resolves without treatment or further consequences

B.An unpleasant taste that causes no medical consequences

C.Brief local discomfort without functional impairment

D.A suspected drug reaction requiring inpatient hospitalisation

Explanation: Inpatient hospitalisation is one criterion for regulatory seriousness, alongside outcomes such as death, life-threatening illness, significant disability, or congenital abnormality. Seriousness is an outcome-based classification and differs from the intensity described by the word severe; medically important events can also qualify.

8The approved SmPC and patient leaflet display an inverted black triangle (▼) with an additional-monitoring statement. What does this symbol mean?

A.The medicine is subject to additional safety monitoring and suspected reactions should be reported

B.The medicine is necessarily a controlled narcotic

C.The medicine's marketing authorisation has been suspended

D.Every package must also display the triangle as a toxicity classification

Explanation: The triangle identifies medicines subject to additional monitoring and encourages reporting of suspected adverse reactions. It is not a declaration that the medicine is unsafe; ALIMS's product-information template places the statement in the SmPC and leaflet rather than establishing a package toxicity symbol.

9During prescription review, a pharmacist finds a dose that appears dangerously excessive for the patient's renal function. What is the appropriate action before dispensing?

A.Dispense because a prescriber's signature transfers all responsibility

B.Reduce the dose silently and leave the original instructions unchanged

C.Dispense and advise the patient to decide how much to take

D.Withhold the unsafe supply while promptly clarifying the prescription and documenting the intervention

Explanation: Serbian Good Pharmacy Practice requires the pharmacist to assess dosing problems and not supply a prescription medicine when it may endanger the patient. Promptly contact the prescriber, arrange a safe resolution, and document the intervention rather than relying on a signature or silently changing therapy.

10A pharmacist needs the approved professional information about a medicine's indications, contraindications, interactions, and storage. Which document should be consulted?

A.The Summary of Product Characteristics (Sažetak karakteristika leka, SmPC)

B.A wholesaler's ordering catalogue

C.The current RFZO reimbursement list alone

D.The pharmacy's stock receipt for the batch

Explanation: The SmPC contains the authorised professional product information, including clinical use and pharmaceutical particulars. Use the current version for the exact product; reimbursement and commercial information do not establish its safe-use conditions.

About the Stručni ispit za magistre farmacije Exam

The Ministry's professional examination follows the pharmacy internship and is part of the route toward professional licensure. Farmaceutska komora Srbije has separate registration and licensing responsibilities. This bank provides selected medicine-safety and pharmacy-knowledge practice rather than comprehensive coverage of the official programme.

Exam sponsor: Ministry of Health of the Republic of Serbia (Ministarstvo zdravlja Republike Srbije). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The opšti deo covers constitutional order, labour and pension/disability rules, healthcare, health insurance, medicines/devices, and patients' rights. The posebni deo checks professional knowledge needed for independent pharmaceutical activities. The pharmacy internship programme includes community and hospital work in dispensing, preparation, procurement, storage, medicine use, and related professional services. Article 9 permits oral or written examination; published internship durations are not official exam weights.

Time Limit

No fixed duration published in the reviewed Ministry instructions or rulebook.

Passing Score

Položio / nije položio (pass/fail), based on the commission's decision considering both parts; no numerical pass mark specified.

Exam / Certification Fees

12,130 RSD in Ministry instructions checked 10 October 2026; confirm before payment.

Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Official sources

Ministry pharmacist examination instructions · Source checked 2026-10-10Current 2026 instructions with a September 2026 session heading, 12,130 RSD fee, application requirements, and community/hospital internship rotations.
Pravilnik o pripravničkom stažu i stručnom ispitu zdravstvenih radnika, 33/2019 · Source checked 2026-10-10General/special assessment, oral or written mode, commission decision, minimum 30-day retake interval, and pharmacy internship scope. No fixed duration, item count, or permitted assessment languages specified.
Law on Health Care — official legal information system · Source checked 2026-10-10Professional-examination and separate licensing requirements, including the 12-month period after internship completion.
Pharmaceutical Chamber — Good Pharmacy Practice documents · Source checked 2026-10-10Content cluster: regulated pharmacy services, compounding, storage, quality, and dispensing.
Good Pharmacy Practice — dispensing annex 6a · Source checked 2026-10-10Content cluster: review for dosing and interaction problems, refusal of unsafe supply, counselling, and product instructions.
ALIMS — consolidated prescription rulebook · Source checked 2026-10-10Content cluster: Article 13 gives ordinary non-renewable prescriptions 15-day validity with specific exceptions. Current ALIMS regulations index lists amendments through 101/2024.
ALIMS — 2026 annotated product-information template · Source checked 2026-10-10Content cluster: additional-monitoring triangle in SmPC and patient leaflet; not a general packaging toxicity symbol.
ALIMS — warfarin product information · Source checked 2026-10-10Content cluster: metronidazole can potentiate warfarin; closer monitoring is required rather than a universal percentage dose change.
ALIMS — atorvastatin product information · Source checked 2026-10-10Content cluster: clarithromycin interaction and increased muscle-toxicity risk.
ALIMS — metformin product information · Source checked 2026-10-10Content cluster: severe renal dysfunction, acute illness, and lactic-acidosis precautions.
EMA — sterilisation guideline · Source checked 2026-10-10Content cluster: distinguish terminal sterilisation from validated filtration followed by aseptic filling.
EMA — Praxbind product information · Source checked 2026-10-10Content cluster: idarucizumab as specific dabigatran reversal.
RFZO — current reimbursed medicine lists · Source checked 2026-10-10Content cluster: compulsory-insurance coverage differs from marketing authorisation and depends on current list conditions.

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

12/40 practice items; official weight unpublished

Pharmaceutical legislation and regulations

Selected medicine-regulatory and professional-service questions.

12/40 practice items; official weight unpublished

Pharmacotherapy and clinical pharmacy

Mechanisms, interaction recognition, toxicity, and safety assessment.

8/40 practice items; official weight unpublished

Pharmaceutical technology and compounding

Formulation principles, ophthalmic quality, sterile processing, and calculations.

8/40 practice items; official weight unpublished

Dispensing and patient counselling

Quantities, interactions, devices, and product-specific storage and use.

Preparing for the Stručni ispit za magistre farmacije Exam

What You Need to Know

Passing score: Položio / nije položio (pass/fail), based on the commission's decision considering both parts; no numerical pass mark specified.
Assessment: The opšti deo covers constitutional order, labour and pension/disability rules, healthcare, health insurance, medicines/devices, and patients' rights. The posebni deo checks professional knowledge needed for independent pharmaceutical activities. The pharmacy internship programme includes community and hospital work in dispensing, preparation, procurement, storage, medicine use, and related professional services. Article 9 permits oral or written examination; published internship durations are not official exam weights.
Time limit: No fixed duration published in the reviewed Ministry instructions or rulebook.
Exam / certification fees: 12,130 RSD in Ministry instructions checked 10 October 2026; confirm before payment. Official sources

Using Our Practice Resources

Work through all 40 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

Stručni ispit za magistre farmacije: Suggested Study Strategy

1Read the current Serbian prescription rules and distinguish ordinary, renewable, antibiotic, controlled, and emergency prescriptions.

2Use the current SmPC and leaflet for the exact product rather than applying universal expiry, storage, or dose-adjustment rules.

3Work through calculation units and final-volume assumptions before checking the answer.

4Practise patient counselling and professional explanations aloud in the assessment language confirmed for your sitting.

5Use supervised practical work for compounding and dispensing skills that MCQs cannot assess.

Frequently Asked Questions

Is this an examination administered by the Pharmaceutical Chamber?

The initial stručni ispit described here is administered by the Ministry of Health. The Chamber's registration and practice-licensing requirements are separate; an examination certificate is not itself a licence.

What format and assessment language should I expect?

The rulebook permits oral or written examination. The reviewed sources do not specify permitted assessment languages or confirm that English is available. Check the actual Ministry session arrangements.

What practical work is mandatory?

The supervised internship and its certified booklet are prerequisites. The reviewed rulebook does not list an additional exam-day compounding station, case-study submission, project, or take-home assignment. Confirm any session requirements and continue practical and spoken-answer preparation.

What does this 40-question bank leave for further study?

It samples pharmacy knowledge. The legal questions concentrate on pharmacy regulation and do not cover every constitutional, labour, pension/disability, insurance, or patient-rights topic in the general part. Practical compounding, full therapeutic breadth, and extended counselling also require additional study.